Meluzio Michael Vincent's Form 4 filing
Cue Biopharma, Inc. (CUE) · filed Aug 17, 2026
- Accession no.
- 0002138368-26-000007
- Filed
- Aug 17, 2026, 6:19 PM ET
- Trade date
- Aug 13, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $169.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Meluzio Michael VincentCIK 0002138368 | Officer (VP, Prin. Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | MOption exerciseAcquired | +13,647 | $0.00 | $0 | 54,589 | Direct | |
| Aug 13, 2026 | Common Stock | SSaleDisposed | −1,519 | $29.37 | −$44,613.03 | 53,070 | Direct | |
| Aug 13, 2026 | Common Stock | SSaleDisposed | −4,106 | $30.35 | −$124,617.1 | 48,964 | Direct | |
| Aug 13, 2026 | Common Stock | SSaleDisposed | −3 | $31.13 | −$93.39 | 48,961 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Common Stock | MOption exerciseDisposed | −13,647 | $0.00 | $0 | 27,295 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.